医学
疾病
生物标志物
个性化医疗
癌症
临床试验
成像生物标志物
重症监护医学
生物信息学
放射科
病理
内科学
磁共振成像
生物
生物化学
作者
Sreyashi Das,Mohan Kumar Dey,Ram Devireddy,Manas Ranjan Gartia
出处
期刊:Sensors
[MDPI AG]
日期:2023-12-20
卷期号:24 (1): 37-37
被引量:28
摘要
Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis, prognosis, treatment response, and personalized medicine. They serve as objective indicators, enabling early detection and intervention, leading to improved patient outcomes and reduced costs. Biomarkers also guide treatment decisions by predicting disease outcomes and facilitating individualized treatment plans. They play a role in monitoring disease progression, adjusting treatments, and detecting early signs of recurrence. Furthermore, biomarkers enhance drug development and clinical trials by identifying suitable patients and accelerating the approval process. In this review paper, we described a variety of biomarkers applicable for cancer detection and diagnosis, such as imaging-based diagnosis (CT, SPECT, MRI, and PET), blood-based biomarkers (proteins, genes, mRNA, and peptides), cell imaging-based diagnosis (needle biopsy and CTC), tissue imaging-based diagnosis (IHC), and genetic-based biomarkers (RNAseq, scRNAseq, and spatial transcriptomics).
科研通智能强力驱动
Strongly Powered by AbleSci AI